N-Nitroso Sitagliptin Fumarate Adduct D4

N-Nitroso Sitagliptin Fumarate Adduct D4 is a chemical compound that is used in the pharmaceutical industry as a treatment for type 2 diabetes. It is a derivative of Sitagliptin, a popular medication used to lower blood sugar levels in diabetic patients. N-Nitroso Sitagliptin Fumarate Adduct D4 is an adduct of Sitagliptin and fumaric acid, and it is known for its potent inhibitory effects on dipeptidyl peptidase-4 (DPP-4), an enzyme that breaks down incretin hormones in the body. The chemical structure of N-Nitroso Sitagliptin Fumarate Adduct D4 consists of a nitroso group (-NO) attached to the Sitagliptin molecule, which increases its potency as a DPP-4 inhibitor. Additionally, the fumarate group in the molecule enhances its solubility and bioavailability in the body. In terms of usage, N-Nitroso Sitagliptin Fumarate Adduct D4 is typically administered orally as a tablet or capsule. It works by increasing the levels of incretin hormones in the body, which stimulate the production of insulin and reduce glucose production in the liver. This results in lower blood sugar levels and improved glycemic control in diabetic patients. Overall, N-Nitroso Sitagliptin Fumarate Adduct D4 is an effective and safe medication for the treatment of type 2 diabetes. However, like all medications, it should only be used under the guidance of a qualified healthcare professional.